940-31-8 Usage
Description
2-Phenoxypropionic acid is an organic compound characterized by its white to pale yellow to beige powder form. It is known for its potential as a herbicide and its involvement in organic chemistry reduction reactions, particularly in the synthesis of PPAR (peroxisome proliferator-activated receptor) ligands.
Uses
Used in Organic Chemistry:
2-Phenoxypropionic acid is used as a reagent in reduction reactions for organic chemistry, contributing to the synthesis of various chemical compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Phenoxypropionic acid is used as a precursor in the synthesis of PPAR ligands, which are important for the development of drugs targeting metabolic diseases.
Used in Agrochemical Industry:
2-Phenoxypropionic acid and its derivatives are utilized as potential herbicides, playing a crucial role in controlling and managing unwanted plant growth in agricultural settings.
Used in Enzymatic Reactions:
The solvent-induced inversion of enantioselectivity during the esterification of 2-phenoxypropionic acid, catalyzed by Candida cylindracea lipase, highlights its application in enzymatic reactions for the production of enantiomerically pure compounds, which are essential in various chemical and pharmaceutical processes.
Synthesis Reference(s)
The Journal of Organic Chemistry, 43, p. 772, 1978 DOI: 10.1021/jo00398a070
Purification Methods
Crystallise the acid from water. [Beilstein 6 H 163, 6 II 158, 6 III 614.]
Check Digit Verification of cas no
The CAS Registry Mumber 940-31-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 9,4 and 0 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 940-31:
(5*9)+(4*4)+(3*0)+(2*3)+(1*1)=68
68 % 10 = 8
So 940-31-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H10O3/c1-7(9(10)11)12-8-5-3-2-4-6-8/h2-7H,1H3,(H,10,11)/p-1/t7-/m1/s1
940-31-8Relevant articles and documents
INHIBITORS TO TARGET HIV-1 NEF-CD80/CD86 INTERACTIONS FOR THERAPEUTIC INTERVENTION
-
Paragraph 000169; 000186; 000187; 000188, (2020/03/05)
The compounds of Formula I, II, and III along with their stereoisomers, pharmaceutically acceptable salts, polymorphs, solvates and hydrates thereof are described in the present disclosure. The said compounds restore immune activation in case of infections or a disease associated with an HIV infection in a subject in need thereof.
PRMT5 INHIBITORS AND USES THEREOF
-
Paragraph 0267-0268, (2019/04/05)
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.
PRMT5 INHIBITORS CONTAINING A DIHYDRO- OR TETRAHYDROISOQUINOLINE AND USES THEREOF
-
Paragraph 00275, (2014/07/08)
Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5- mediated disorders are also described.
